Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
28.87
+0.61 (+2.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Guardant Health Inc
< Previous
1
2
3
4
5
6
7
Next >
From ‘Sell’ to ‘Strong Buy’: 3 Dramatic Analyst U-Turns to Watch
Today 6:15 EDT
These are three stocks with analyst upgrades worth looking into thanks to their niche specializations and long-term prospects.
Via
InvestorPlace
Where Guardant Health Stands With Analysts
June 28, 2024
Via
Benzinga
Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
May 29, 2024
On Wednesday, Ark Invest, led by the influential investor Cathie Wood, executed notable trades involving Robinhood Markets Inc (NASDAQ:HOOD), Moderna Inc (NASDAQ:MRNA), Palantir
Via
Benzinga
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns
May 27, 2024
We're heading into our third year of this raging bull market, and there doesn't appear to be any end in sight for these high-return stocks.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 27, 2024
Via
Benzinga
Evaluating Guardant Health: Insights From 5 Financial Analysts
May 24, 2024
Via
Benzinga
Key Takeaways From Guardant Health Analyst Ratings
April 24, 2024
Via
Benzinga
Analyst Expectations For Guardant Health's Future
April 05, 2024
Via
Benzinga
Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday
May 24, 2024
Via
Benzinga
FDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening
May 24, 2024
FDA panel recommends approval for Guardant Health's Shield blood test for colorectal cancer screening.
Via
Benzinga
Exposures
Product Safety
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
May 24, 2024
The companies are likely to soon battle it out in the colon cancer screening market.
Via
Investor's Business Daily
Exposures
Product Safety
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
May 21, 2024
FDA staff reviewers raise concerns over Guardant Health's experimental Shield blood test for colorectal cancer, citing low sensitivity in detecting certain tumor types. Shield aims to improve early CRC...
Via
Benzinga
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
May 14, 2024
Via
Benzinga
4 Analysts Have This To Say About Guardant Health
February 23, 2024
Via
Benzinga
Guardant Health: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Decoding 4 Analyst Evaluations For Guardant Health
January 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 10, 2024
Via
Benzinga
GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
GH stock results show that Guardant Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
April 22, 2024
Via
Benzinga
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
April 02, 2024
The companies are working to detect colon cancer and precancerous markers in blood and/or stool.
Via
Investor's Business Daily
Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks.
April 01, 2024
These stocks are solid buys according to the advanced AI model Claude 3, which has been touted as potentially superior to ChatGPT.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
March 28, 2024
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat...
Via
Benzinga
Insiders Buying Advance Auto Parts And 2 Other Stocks
March 20, 2024
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
Cancer Test Focused Guardant Health Stock Falls On FDA AdCom Update For Colorectal Test
February 23, 2024
Guardant Health surpasses Q4 2023 revenue expectations, reporting $155.1 million. Precision oncology revenue is up 25% to $142.2 million. Adjusted EPS loss beats consensus. Update on Shield CRC...
Via
Benzinga
Exposures
Product Safety
3 Stocks to Buy for the Age of Personalized Medicine
January 28, 2024
Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider.
Via
InvestorPlace
Bull of the Day - NeoGenomics
January 12, 2024
But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
January 08, 2024
Small cap stocks are anticipated to rise by as much as 50% in 2024 as investors look for growth in new areas of the market.
Via
InvestorPlace
4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024
January 08, 2024
Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run.
Via
The Motley Fool
Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise Advisory Possibility: Analyst
December 20, 2023
Tuesday, Guardant Health Inc (NASDAQ: GH) announced that the FDA's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review the premarket...
Via
Benzinga
Exposures
Product Safety
S&P 500, Nasdaq Set For Weaker Open As 'FOMO' Rally Cools: Analyst Says Only 'Black Swan Could Upset Santa's Sleigh' Now
December 20, 2023
Bond yields remain contained, providing a reason for traders to maintain their investments in stocks.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.